Authors:
Vukosavic, S
Ruzdijic, S
Veskov, R
Rakic, L
Kanazir, S
Citation: S. Vukosavic et al., Differential effects of amphetamine and phencyclidine on the expression ofgrowth-associated protein GAP-43, NEUROSCI RE, 40(2), 2001, pp. 133-140
Authors:
Vila, M
Jackson-Lewis, V
Vukosavic, S
Djaldetti, R
Liberatore, G
Offen, D
Korsmeyer, SJ
Przedborski, S
Citation: M. Vila et al., Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease, P NAS US, 98(5), 2001, pp. 2837-2842
Authors:
Przedborski, S
Chen, QP
Vila, M
Giasson, BI
Djaldatti, R
Vukosavic, S
Souza, JM
Jackson-Lewis, V
Lee, VMY
Ischiropoulos, H
Citation: S. Przedborski et al., Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease, J NEUROCHEM, 76(2), 2001, pp. 637-640
Authors:
Vukosavic, S
Stefanis, L
Jackson-Lewis, V
Guegan, C
Romero, N
Chen, CP
Dubois-Dauphin, M
Przedborski, S
Citation: S. Vukosavic et al., Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis, J NEUROSC, 20(24), 2000, pp. 9119-9125
Authors:
Keckarevic, D
Culjkovic, B
Savic, D
Stojkovic, O
Kostic, V
Vukosavic, S
Romac, S
Citation: D. Keckarevic et al., The status of SCA1, MJD/SCA3, FRDA, DRPLA and MD triplet containing genes in patients with Huntington disease and healthy controls, J NEUROGEN, 14(4), 2000, pp. 257-263
Authors:
Culjkovic, B
Stojkovic, O
Savic, D
Zamurovic, N
Nesic, M
Major, T
Keckarevic, D
Romac, S
Zamurovic, B
Vukosavic, S
Citation: B. Culjkovic et al., Comparison of the number of triplets in SCA1, MJD/SCA3, HD, SBMA, DRPLA, MD, FRAXA and FRDA genes in schizophrenic patients and a healthy population, AM J MED G, 96(6), 2000, pp. 884-887
Authors:
Vila, M
Vukosavic, S
Jackson-Lewis, V
Neystat, M
Jakowec, M
Przedborski, S
Citation: M. Vila et al., alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP, J NEUROCHEM, 74(2), 2000, pp. 721-729
Authors:
Liberatore, GT
Jackson-Lewis, V
Vukosavic, S
Mandir, AS
Vila, M
McAuliffe, WG
Dawson, VL
Dawson, TM
Przedborski, S
Citation: Gt. Liberatore et al., Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease, NAT MED, 5(12), 1999, pp. 1403-1409
Authors:
Vukosavic, S
Dubois-Dauphin, M
Romero, N
Przedborski, S
Citation: S. Vukosavic et al., Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis, J NEUROCHEM, 73(6), 1999, pp. 2460-2468
Authors:
Almer, G
Vukosavic, S
Romero, N
Przedborski, S
Citation: G. Almer et al., Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis, J NEUROCHEM, 72(6), 1999, pp. 2415-2425